Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alexandria To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Alexandria between January 27, 2025 and October 27, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- ...

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose material adverse facts concerning its Phase 3 PALISADE-3 trial study of fasedienol, an ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Vistagen Therapeutics, Inc. due to allegations of violations of federal securities laws related to misleading statements about the company's clinical trial results [2][5]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who suffered losses in Vistagen between April 1, 2024, and December 16, 2025, to discuss their legal rights [1]. - A federal securities class action has been filed against Vistagen, with a deadline of March 16, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that Vistagen and its executives made false statements regarding the likelihood of success in the PALISADE-3 clinical trial, which misled investors and caused them to purchase shares at inflated prices [5]. Group 2: Clinical Trial Results and Market Impact - On December 17, 2025, Vistagen announced that its PALISADE-3 study for fasedienol failed to meet its primary efficacy endpoint, leading to a significant stock price drop of over 81%, opening at $0.88 per share [6]. - The study did not demonstrate statistically significant improvement in anxiety reduction compared to placebo, which contradicted previous positive assertions made by the company [5][6]. Group 3: Firm Background and Contact Information - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Vistagen's conduct [8].

Core Viewpoint - Fermi Inc. is facing a federal securities class action due to allegations of misleading statements regarding its Project Matador campus and tenant commitments, leading to significant investor losses following the termination of a key funding agreement [5][8]. Group 1: Company Overview - Fermi Inc. (NASDAQ: FRMI) completed its IPO on October 1, 2025, offering approximately 32.5 million shares at $21.00 per share, with plans to develop a large electric generation campus for AI data centers [6]. - The registration statement highlighted a "First Tenant" for the Project Matador site, which was expected to lease a portion of the site under a long-term agreement [6]. Group 2: Allegations and Legal Actions - The complaint against Fermi alleges that the company overstated tenant demand and relied heavily on a single tenant's funding commitment, which posed a significant risk of termination [5]. - On December 12, 2025, Fermi disclosed that the First Tenant had terminated the Advance in Aid of Construction Agreement, which was crucial for funding the Project, resulting in a stock price drop of over 33% to $10.09 per share [8]. Group 3: Investor Actions - Faruqi & Faruqi, LLP is encouraging investors who suffered losses during the class period from October 1, 2025, to December 11, 2025, to discuss their legal options [2][10]. - The deadline for investors to seek the role of lead plaintiff in the class action is March 6, 2026 [2].

Core Viewpoint - The law firm Kirby McInerney LLP is investigating Navan, Inc. for potential violations of federal securities laws and other unlawful business practices following its recent IPO and subsequent financial disclosures [1][3]. Group 1: Company Overview - Navan, Inc. conducted its initial public offering on October 30, 2025, selling approximately 36.9 million shares at a price of $25.00 per share [3]. - The company reported a GAAP loss from operations of $79 million for the third quarter of fiscal 2026, compared to a loss of $19 million in the same period the previous year [3]. - Navan's GAAP operating margin was reported at (41%), a significant decline from (13%) in the same quarter of the previous year [3]. Group 2: Management Changes - Following the financial results announcement, Navan's CFO stepped down immediately, just six weeks post-IPO [3]. - The company agreed to provide the departing CFO with accelerated vesting of 100% of unvested restricted stock units and stock options, along with a cash payment of $3.7 million [3]. Group 3: Market Reaction - The announcement of the CFO's departure and the financial results led to a decline in Navan's share price by $1.74, or approximately 11.9%, dropping from $14.64 on December 15, 2025, to $12.90 on December 16, 2025 [3].

New York, New York--(Newsfile Corp. - January 21, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Wealthfront Corporation ("Wealthfront Corporation") (NASDAQ: WLTH) concerning potential violations of the federal securities laws.On January 13, 2026, Barron's reported that shares of Wealthpoint "dropped 14% Tuesday morning after the wealth management company reported quarterly earnings and provided data on Monday afternoon that showed some softening in asset flows in N ...

Core Viewpoint - Kahn Swick & Foti, LLC is investigating United Natural Foods, Inc. for potential breaches of fiduciary duties by its officers and directors, following significant financial declines and a securities class action lawsuit against the company [1][3]. Financial Performance - In March 2023, United Natural reported a year-over-year decline of $6 million in gross profit and over 71% in net income and earnings per diluted share for its fiscal 2023 second quarter, despite a 6% increase in net sales [2]. - The company reduced its adjusted EBITDA guidance by approximately $115 million, or about 13.3%, primarily due to lower procurement and inventory gains, influenced by supply chain volatility and a slowdown in inflation rates [2]. Legal Issues - Following the financial disclosures, United Natural and certain executives faced a securities class action lawsuit for allegedly failing to disclose material information, violating federal securities laws [2]. - A court has denied the company's Motion for Judgment on the Pleadings, allowing the lawsuit to proceed [2]. Investigation Focus - KSF's investigation is centered on whether United Natural's leadership breached their fiduciary duties to shareholders or violated state or federal laws [3].

Core Viewpoint - Kahn Swick & Foti, LLC has initiated an investigation into Crocs, Inc. regarding potential breaches of fiduciary duties by its officers and directors, following disappointing financial results from its HEYDUDE acquisition and ongoing securities class action lawsuits [1][3]. Group 1: Company Performance - In February 2022, Crocs completed the acquisition of HEYDUDE, a brand focused on casual and lightweight footwear [2]. - On October 29, 2024, Crocs reported that HEYDUDE's revenues fell below expectations, indicating that the brand's performance and market conditions suggest a longer turnaround time than initially anticipated due to excess inventories [2]. Group 2: Legal Issues - Following the disappointing performance of HEYDUDE, Crocs and certain executives are facing a securities class action lawsuit for failing to disclose material information, which is still ongoing [3]. - Kahn Swick & Foti's investigation is centered on whether Crocs' leadership violated state or federal laws or breached their fiduciary duties to shareholders [3].

Core Viewpoint - Kahn Swick & Foti, LLC has initiated an investigation into Charles River Laboratories International, Inc. following legal issues related to the company's supply chain practices and securities disclosures [1][3]. Group 1: Legal Issues - In February 2023, Charles River disclosed it received a subpoena from the U.S. Department of Justice regarding an investigation into the illegal importation of non-human primates, leading to a voluntary suspension of shipments from Cambodia [2]. - The suspension is expected to negatively impact the company's earnings for the year, reducing revenue growth by 200 to 400 basis points [2]. - Following the subpoena, Charles River and certain executives were sued in a securities class action lawsuit for failing to disclose material information, which is still ongoing [3]. Group 2: Investigation Focus - KSF's investigation is centered on whether Charles River's officers and/or directors breached their fiduciary duties to shareholders or violated state or federal laws [3].

Core Viewpoint - Kahn Swick & Foti, LLC has initiated an investigation into Hasbro, Inc. regarding potential breaches of fiduciary duties by its officers and directors, following a significant decline in the company's Consumer Product revenues and a related securities class action lawsuit [1][2][3]. Financial Performance - Hasbro reported an 18% year-over-year decline in Consumer Product revenues for Q3 2023, attributed to exited businesses, soft industry trends, and inventory management prioritization [2]. - The company revised its full-year guidance for Consumer Product revenue, now expecting a decline of 13% to 15%, a significant increase from the previously forecasted decline of 3% to 6% [2]. Legal Issues - Following the financial disclosures, Hasbro and certain executives are facing a securities class action lawsuit for allegedly failing to disclose material information, which is currently ongoing [2]. - Kahn Swick & Foti's investigation is focused on whether there were any violations of state or federal laws by Hasbro's leadership [3].